• 1

    Effect of 52 % low-sodium salt applied to CM-DASH diet on atherosclerotic cardiovascular disease risks in patients with hypertension and type-2 diabetes

    Nutrición Hospitalaria 2022;39(4): 778-785

    TANG J, CHEN D, MU L, YU P, GONG T, XU H, ZHANG Z, CAI S, MEI Y

    Nutrición Hospitalaria 2022;39(4): 778-785

    Tipo artículo:

    Resumen del Autor: AbstractIntroduction:hypertension and diabetes are chronic disorders associated with an increased risk of cardiovascular disease.Objectives:to evaluate the effect of 52 % low-sodium salt applied to the Chinese-modified DASH (CM-DASH) diet on risk of atherosclerotic cardiovascular disease (ASCVD) in patients with hypertension and type-2 diabetes.Methods:the low-sodium salt group (LSSG) took 5 g/day of 52 % low-sodium salt plus CM-DASH diet for 8 weeks, while the normal-sodium salt group (NSSG) took the same dose of normal-sodium salt plus CM-DASH diet for 8 weeks. Blood tests, 24-hour urine tests, anthropometric measurements, and 10-year risk of ASCVD prediction were assessed.Results:compared with baseline, both LSSG and NSSG showed a significant reduction in 10-year risk of ASCVD, but we did not find any statistically significant differences in 10-year risk of ASCVD between LSSG and NSSG.Conclusions:our study shows that salt limits and DASH diets reduce the risk of cardiovascular disease whereas low-sodium salt containing 52 % sodium chloride did not significantly lower the risk of cardiovascular disease when compared to regular salt. Due to the limitations of the research, additional studies will be necessary to confirm our findings.

    Notas:

     

    Palabras clave: Endocrinología, Nutrición

    ID MEDES: 173124 [En proceso]



    * RECUERDE. Al pulsar el enlace “Texto completo”, usted abandonará el entorno MEDES. En ese caso, la web a la que desea acceder no es propiedad de Fundación Lilly y, por tanto, ésta no se responsabiliza de los contenidos, informaciones o servicios presentes en ella, ni de la política de privacidad que aplique el sitio web de un tercero.